Skip Navigation
Skip to contents

Scientific Program

Filter
SELECT AND VIEW SESSIONS OF YOUR CHOICE
Search

[JS01] Joint Session 01 (Asia Session)

New Era of MPN Treatment

Galaxy Theater
  • March 26 (Thu), 09:00-10:15
  • Sung-Yong Kim (Konkuk University School of Medicine, Korea)
    Hsin-An Hou (National Taiwan University Hospital, Taiwan)
  • 09:00-09:20 Advances and Insights in Molecular Monitoring for Myeloproliferative Neoplasms Hsin-An Hou (National Taiwan University Hospital, Taiwan) 09:20-09:40 Evolving Treatment Paradigms in Early Myelofibrosis Winnie Teo (Alexandra Hospital, Singapore) 09:40-10:00 Optimizing Treatment Strategies in Higher MF and Beyond Sung-Eun Lee (College of Medicine, The Catholic University of Korea, Korea) 10:00-10:15 Discussion

[SS01] Scientific Session 01

Novel Managements Tools for Hemophilia

Discovery Hall
  • March 26 (Thu), 09:00-10:15
  • Eun Jin Choi (Daegu Catholic University School of Medicine, Korea)
    Jung Woo Han (Yonsei University College of Medicine, Korea)
  • 09:00-09:25 Recent Advances in the Diagnosis and Management of Acquired Hemophilia A Shin Young Hyun (Yonsei University College of Medicine, Korea) 09:25-09:50 Clinical Advances and Challenges in Gene Therapy for Hemophilia Ben Samelson-Jones (The Children's Hospital of Philadelphia, USA) 09:50-10:15 Role of Bispecific Antibody in Hemophilia Claude Négrier (University of Lyon, France)

[SS02] Scientific Session 02

ALL 2026: Shifting Standards and Emerging Innovations

Universe Arena
  • March 26 (Thu), 09:00-10:15
  • Seok Lee (Ewha Womans University College of Medicine, Korea)
    Won Sik Lee (Inje University College of Medicine, Korea)
  • 09:00-09:25 Integration of MRD and Genetics as a Therapeutic Guidepost in ALL Anthony Moorman (Newcastle University, UK) 09:25-09:50 Modern Immunotherapeutics in B-ALL: BiTEs, ADCs, and Beyond Jae-Ho Yoon (College of Medicine, The Catholic University of Korea, Korea) 09:50-10:15 Optimizing Frontline Therapy in Ph+ ALL: The Role of Ponatinib and Beyond Nicholas J. Short (The University of Texas MD Anderson Cancer Center, USA)

[ES01] Education Session 01

FOCUS ON: Indolent B-cell Lymphomas

Supernova Stage
  • March 26 (Thu), 09:00-10:15
  • Jeong A Kim (College of Medicine, The Catholic University of Korea, Korea)
    Jeong-Ok Lee (Seoul National University College of Medicine, Korea)
  • 09:00-09:25 Mantle Cell Lymphoma Jaewon Hyung (University of Ulsan College of Medicine, Korea) 09:25-09:50 Chronic Lymphocytic Leukemia Jongheon Jung (National Cancer Center, Korea) 09:50-10:15 Marginal Zone Lymphoma Sang-A Kim (Seoul National University College of Medicine, Korea)

[PL01] Plenary Lecture 01

Galaxy Theater & Discovery Hall
  • March 26 (Thu), 10:30-11:15
  • Hee-Je Kim (College of Medicine, The Catholic University of Korea, Korea)
  • 10:30-11:15 What Makes a Stem Cell and How Does It Go Bad John E. Dick (University Health Network, Canada)

[PS01] Presidential Symposium

Galaxy Theater & Discovery Hall
  • March 26 (Thu), 11:15-12:00
  • Seok Jin Kim (Sungkyunkwan University School of Medicine, Korea)
  • 11:15-12:00 Mechanism-Driven Combination Targeted Therapies for Diffuse Large B-cell Lymphoma Wyndham H. Wilson (National Cancer Institute, USA)

[SY01] Satellite Symposium 01

Roche Korea

Galaxy Theater
  • March 26 (Thu), 12:15-13:05
  • Seok Jin Kim (Sungkyunkwan University School of Medicine, Korea)
  • 12:15-13:05 Recent Insights on DLBCL Treatment: Focused on Polatuzumab and Glofitamab Matthew Matasar (Rutgers Cancer Institute, USA)

[SY02] Satellite Symposium 02

GC Biopharma

Discovery Hall
  • March 26 (Thu), 12:15-13:05
  • Won Seog Kim (Sungkyunkwan University School of Medicine, Korea)
  • 12:15-13:05 Immunoglobulin Replacement in the Era of Cellular and Bispecific Therapies Ja Min Byun (Seoul National University College of Medicine, Korea)

[SY03] Satellite Symposium 03

GlaxoSmithKline

Universe Arena
  • March 26 (Thu), 12:15-13:05
  • Jin Seok Kim (Yonsei University College of Medicine, Korea)
  • 12:15-13:05 Changing the Survival Landscape in RRMM with Novel ADC Sung-Hoon Jung (Chonnam National University Medical School, Korea)

[SY04] Satellite Symposium 04

AbbVie Korea

Supernova Stage
  • March 26 (Thu), 12:15-13:05
  • Dok Hyun Yoon (University of Ulsan College of Medicine, Korea)
  • 12:15-13:05 Epcoritamab in 3L+ DLBCL: Updates on Clinical Trial and Real World Data in the Evolving DLBCL Treatment Pathway William Townsend (University College London Hospitals NHS Foundation Trust, UK)

[SY05] Satellite Symposium 05

Novartis Korea

Grand 4+5
  • March 26 (Thu), 12:15-13:05
  • Sung-Hyun Kim (Dong-A University College of Medicine, Korea)
  • 12:15-13:05 Advancing CML Treatment with Clinical Insights on Asciminib Eri Matsuki (Keio University School of Medicine, Japan)

[OP01] Oral Presentation 01

Acute Leukemia 1

Galaxy Theater
  • March 26 (Thu), 13:55-15:10
  • Jae Wook Lee (College of Medicine, The Catholic University of Korea, Korea)
    Joon Ho Moon (Kyungpook National University School of Medicine, Korea)
  • 13:55-14:07 Development and Internal Validation of a Simple Three-Gene Risk Score for Elderly AML Patients Receiving Nonintensive Therapy Sang-A Kim (Seoul National University Bundang Hospital, Korea) 14:07-14:19 The Impact of RUNX1-RUNX1T1 Transcript Kinetics and Co-Mutation on the Post-Transplant Outcomes in Acute Myeloid Leukemia with t(8;21): A Real-World Study Yi Xia (Peking University People’s Hospital, China) 14:19-14:31 Prognostic Heterogeneity and Treatment Outcomes in TP53 Mutated Acute Myeloid Leukemia: A Prospective Nationwide Multicenter Study Mihee Kim (Chonnam National University Hwasun Hospital, Korea) 14:31-14:43 Comprehensive Prognostic Stratification by Gene Deletion Profiles in Adult Patients with BCP-ALL: Distinct Biological and Clinical Implications in Ph-Negative and Ph-Positive ALL Jae-Ho Yoon (College of Medicine, The Catholic University of Korea, Korea) 14:43-14:55 Revealing Subtype-Specific Immunophenotypic and Cytogenetic Patterns That Improve Detection of Measurable Residual Disease in B-Lymphoblastic Leukemia Ju Hyeong Lee (Seoul National University Hospital, Korea) 14:55-15:07 Impact of End-of-Induction Measurable Residual Disease Status across Cytogenetic Subtypes among Pediatric Patients with B-Lineage Acute Lymphoblastic Leukemia: Do TCF3::PBX1 Patients Warrant Altered Risk Stratification and Treatment? Karthik Bommannan Bommannan Kuppuraju (Cancer Institute (W.I.A), India)

[OP02] Oral Presentation 02

Myelodysplastic Syndrome & Myeloproliferative Neoplasm

Discovery Hall
  • March 26 (Thu), 13:55-15:10
  • Dong-Yeop Shin (Seoul National University College of Medicine, Korea)
    Sung-Eun Lee (College of Medicine, The Catholic University of Korea, Korea)
  • 13:55-14:07 ASXL1 Mutation Status Influences the Response to Retinoid-Based Epigenetic Differentiation Therapy in MDS/AML Lukasz Szymanski (Institute of Genetics and Animal Biotechnology, Polish Academy of Sciences, Poland) 14:07-14:19 TP53 Allelic State Defines Infection Susceptibility in Myelodysplastic Syndrome and Acute Myeloid Leukemia Junshik Hong (Seoul National University Hospital, Korea) 14:19-14:31 Therapy-Related Myelodysplastic Syndromes: Clinical Characteristics and Real-World Treatment Outcomes from a Single-Center Cohort Yunsuk Choi (Asan Medical Center, University of Ulsan College of Medicine, Korea) 14:31-14:43 Individualized Decitabine Dosing for Post-HSCT Maintenance in MDS: Long-Term Outcomes from the PODAC Trial and Matched Controls Hohyung Nam (Seoul St. Mary's Hospital, Korea) 14:43-14:55 Ropeginterferon Dose-Escalation Strategies in PV: A Systematic Review and Meta-Analysis Seug Yun Yoon (Soonchunhyang University Seoul Hospital, Korea) 14:55-15:07 Long-Term Molecular Response to Ropeginterferon alfa-2b and Clinical Validation of qPCR for Low-Level JAK2 Monitoring in Polycythemia Vera So Yeon Park (Seoul St. Mary's Hospital, Korea)

[OP03] Oral Presentation 03

Lymphoma

Universe Arena
  • March 26 (Thu), 13:55-15:10
  • Young Hoon Park (Ewha Womans University College of Medicine, Korea)
    Yoon Seok Choi (Korea University College of Medicine, Korea)
  • 13:55-14:07 Phase II Study of Lenalidomide Maintenance after Rituximab-Methotrexate-Based Induction Therapy in Primary CNS Lymphoma Ji Yun Lee (Seoul National University Bundang Hospital, Korea) 14:07-14:19 Phase 1 Study of GCC2005, an Allogeneic CD5-Directed CAR-NK Therapy, for Patients with Relapsed/Refractory NK/T-cell Malignancies Dok Hyun Yoon (Asan Medical Center, University of Ulsan College of Medicine, Korea) 14:19-14:31 Treatment Patterns and Survival Outcomes in Patients with Mantle Cell Lymphoma: Updated Interim Report of the Asia-Pacific Multinational Prospective Registry Study Hyungwoo Cho (Asan Medical Center, University of Ulsan College of Medicine, Korea) 14:31-14:43 Clinical and Functional Impact of CD19-Positive Extracellular Vesicles in CD19 CAR-T Treated Diffuse Large B-cell Lymphoma Bon Park (Sungkyunkwan University, Korea) 14:43-14:55 Longitudinal Whole Exome Sequencing Identifies Clonal Hematopoiesis and Genomic Heterogeneity as Predictors of Treatment Outcome in Newly Diagnosed Chronic Lymphocytic Leukemia Treated with Chlorambucil-Obinutuzumab Ho Cheol Jang (Chonnam National University Hwasun Hospital, Korea) 14:55-15:07 The Role of Maintenance Therapy with PD-1 Inhibitors after Autologous HSCT in Patients with Classical Hodgkin Lymphoma at High Risk of Relapse and Progression Ekaterina Fastova (National Medical Research Center for Hematology, Russia)

[OP04] Oral Presentation 04

General Hematology

Supernova Stage
  • March 26 (Thu), 13:55-15:10
  • Yoon Hwan Chang (Seoul National University College of Medicine, Korea)
    Sung Hwa Bae (Daegu Catholic University School of Medicine, Korea)
  • 13:55-14:07 Long-Term Outcomes and Inhibitor Relapse Following Immune Tolerance Induction in Severe Hemophilia A Patients with Inhibitors: A Prospective Multicenter Study Zhengping Li (Beijing Children's Hospital, Capital Medical University, China) 14:07-14:19 A Reference Laboratory’s Experience with 16 Unstable Hemoglobin Variants over 14 Years: Diagnostic Clues, Pitfalls, and the Role of Sequencing Prashant Sharma (Postgraduate Institute of Medical Education and Research, India) 14:19-14:31 Efficacy of HLA-Matched Platelet Transfusion and Its Predictors in Platelet Refractory Patients with Hematologic Malignancies Jiwoo Lee (Seoul National University Hospital, Korea) 14:31-14:43 Impact of Anti-CD38 Monoclonal Antibody Therapy on Pretransfusion Testing and Transfusion Strategies in Multiple Myeloma Patients at an Eastern Taiwan Medical Center Min-Hsuan Lan (Tzu Chi University, Tzu Chi Hospital, Taiwan) 14:43-14:55 Artificial Intelligence-Optimized Monocytosis Workflow: Transforming Early Detection of Hematologic Malignancies in Automated Hematology Systems Yama Sirly Putri (Faculty of Medicine Indo Global Mandiri University, Indonesia) 14:55-15:07 Clinical Effectiveness and Bleeding Outcomes of Edoxaban for Cancer-Associated Venous Thromboembolism in Korean Patients: A Prospective, Multicenter, Single-Arm, Observational Cohort Study Ho-Young Yhim (Jeonbuk National University Medical School, Korea)

[JS02] Joint Session 02 (MOU Session)

The Present and Future of Bone Marrow Failure Syndrome in Asia

Galaxy Theater
  • March 26 (Thu), 15:25-16:40
  • Jun Ho Jang (Sungkyunkwan University School of Medicine, Korea)
    Ponlapat Rojnuckarin (Chulalongkorn University, Thailand)
  • 15:25-15:45 The Current State of Transplantation for Aplastic Anemia in Vietnam Han Viet Trung (Bach Mai Hospital, Vietnam) 15:45-16:05 Recent Update of the Treatment of Aplastic Anemia in Thailand Ponlapat Rojnuckarin (Chulalongkorn University, Thailand) 16:05-16:25 PNH Management in Korea: Therapeutic Options, Access and Real-World Outcomes Silvia Park (College of Medicine, The Catholic University of Korea, Korea) 16:25-16:40 Discussion

[SS03] Scientific Session 03

Geriatric Hematology

Discovery Hall
  • March 26 (Thu), 15:25-16:40
  • ByungSoo Kim (Korea University College of Medicine, Korea)
    Sangkyun Sohn (Kyungpook National University School of Medicine, Korea)
  • 15:25-15:50 Integrating Comprehensive Geriatric Assessment into Hematology Practice: Identifying Frailty and Optimizing Care for Older Adults Jung-Yeon Choi (Seoul National University Bundang Hospital, Korea) 15:50-16:15 Redefining Risk in Elderly AML: A Geriatric Assessment-Based Approach Byung Sik Cho (College of Medicine, The Catholic University of Korea, Korea) 16:15-16:40 Psycho-Oncological Interventions in Geriatric Hematology: Enhancing Quality of Life Juhee Cho (Samsung Comprehensive Cancer Center, Sungkyunkwan University, Korea)

[SS04] Scientific Session 04

Next-Generation Cell Therapies: In Vivo CAR Engineering, Myeloid Modulation, and Beyond

Universe Arena
  • March 26 (Thu), 15:25-16:40
  • Hyoung Jin Kang (Seoul National University College of Medicine, Korea)
    Young Rok Do (Keimyung University School of Medicine, Korea)
  • 15:25-15:50 Engineered NK Cells for Optimal Anti-Tumor Immunotherapy Challice Bonifant (Johns Hopkins University School of Medicine, USA) 15:50-16:15 Lessons from Hemophagocytic Lymphohistiocytosis: Taming the Cytokine Storm in CAR-T Cell Therapy Michael B. Jordan (Cincinnati Children’s Hospital Medical Center, USA) 16:15-16:40 Tumor-Marrow Axis: Myeloid Reprogramming from Suppression to Activation Seunghee Kim-Schulze (Icahn School of Medicine at Mount Sinai, USA)

[ES02] Education Session 02

Recent Advances in Acute Leukemia

Supernova Stage
  • March 26 (Thu), 15:25-16:40
  • Chul Won Choi (Korea University College of Medicine, Korea)
    Jae-Sook Ahn (Chonnam National University Medical School, Korea)
  • 15:25-15:50 FLT3-Positive AML Ik-Chan Song (Chungnam National University College of Medicine, Korea) 15:50-16:15 B-cell ALL with HIgh Risk Features in Adults Dong Won Baek (Kyungpook National University School of Medicine, Korea) 16:15-16:40 Understanding and Clinical Approach to Early T-cell Precursor Acute Lymphoblastic Leukemia (ETP-ALL) Hee Young Ju (Sungkyunkwan University School of Medicine, Korea)

[SS05] Scientific Session 05

MDS: Perspectives from Multiple Viewpoints

Galaxy Theater
  • March 26 (Thu), 16:55-18:10
  • Je-Hwan Lee (University of Ulsan College of Medicine, Korea)
    Yoo Jin Kim (College of Medicine, The Catholic University of Korea, Korea)
  • 16:55-17:20 Insights into DDX41 Mutations: Relatively Common Genetic Aberrations in Korean MDS Patients Hongtae Kim (Ulsan National Institute of Science and Technology (UNIST), Korea) 17:20-17:45 Few Drug Approvals in MDS: Lessons and Insights from a Decade of Clinical Trials Maximilian Stahl (Yale University School of Medicine, USA) 17:45-18:10 Clinical Approach to Relapsed or Refractory Lower-Risk Myelodysplastic Syndromes Valeria Santini (University of Florence, Italy)

[SS06] Scientific Session 06

Focus on Telomeres in Hematology

Discovery Hall
  • March 26 (Thu), 16:55-18:10
  • Ho Joon Im (University of Ulsan College of Medicine, Korea)
    Hyeon Jin Park (National Cancer Center, Korea)
  • 16:55-17:20 Recent Advances in the Genetics of Telomere Biology Disorders Sharon A. Savage (National Institutes of Health, USA) 17:20-17:45 Clonal Hematopoiesis in the Short Telomere Syndromes Kristen E. Schratz (Johns Hopkins University School of Medicine, USA) 17:45-18:10 Current Status of Telomere Biology Disorders in Inherited Bone Marrow Failure Inderjeet Dokal (Queen Mary University of London, UK)

[SS07] Scientific Session 07

Advancing Immunotherapy in Multiple Myeloma: Mechanisms and Next-Generation Strategies

Universe Arena
  • March 26 (Thu), 16:55-18:10
  • Jin Seok Kim (Yonsei University College of Medicine, Korea)
    Seong Hyun Jeong (Ajou University School of Medicine, Korea)
  • 16:55-17:20 Next-Generation Effector Cells in Myeloma Immunotherapy Hyunsoo Cho (Seoul National University College of Medicine, Korea) 17:20-17:45 Natural Killer Cell-Based Immunotherapy in Multiple Myeloma Seung-Hwan Lee (University of Ottawa, Canada) 17:45-18:10 Preclinical Optimization of T Cell Redirected Therapy Marta Chesi (Mayo Clinic, USA)

[ES03] Education Session 03

Integrated Laboratory Perspectives in Hematologic Malignancies: From Initial Workup to Transplantation

Supernova Stage
  • March 26 (Thu), 16:55-18:10
  • Hyun Kyung Kim (Seoul National University College of Medicine, Korea)
    Jihyang Im (College of Medicine, The Catholic University of Korea, Korea)
  • 16:55-17:20 Procedures and Interpretation of Bone Marrow Examination Seung Yeob Lee (Jeonbuk National University Medical School, Korea) 17:20-17:45 Diagnostic and Monitoring Approaches Focused on Minimal Residual Disease Miyoung Kim (University of Ulsan College of Medicine, Korea) 17:45-18:10 Laboratory Tests Performed in Blood Bank before and after Hematopoietic Stem Cell Transplantation Dong Wook Jekarl (College of Medicine, The Catholic University of Korea, Korea)

Go top

Go top

Hosted by
Supported by